1. Apoptotic Pathway as the Therapeutic Target for Anticancer Traditional Chinese Medicines
   Weixiao An et al, 2019, Frontiers in Pharmacology CrossRef
2. New therapeutic aspects of steroidal cardiac glycosides: the anticancer properties of Huachansu and its main active constituent Bufalin
   Chien-shan Cheng et al, 2019, Cancer Cell International CrossRef
3. Molecular Signaling Pathways and Therapeutic Targets in Hepatocellular Carcinoma
   Manali Dimri et al, 2020, Cancers CrossRef
4. Bufalin: A Systematic Review of Research Hotspots and Antitumor Mechanisms by Text Mining and Bioinformatics
   Xian Zhang et al, 2020, The American Journal of Chinese Medicine CrossRef
5. Drug resistance and new therapies in gallbladder cancer
   Yuxin Sun et al, 2023, Drug Discoveries & Therapeutics CrossRef
6. Glypican-3: A Novel and Promising Target for the Treatment of Hepatocellular Carcinoma
   Xiufeng Zheng et al, 2022, Frontiers in Oncology CrossRef
7. Bufalin inhibits human diffuse large B-cell lymphoma tumorigenesis by inducing cell death through the Ca2+/NFATC1/cMYC pathway
   Jincheng Song et al, 2021, Carcinogenesis CrossRef
8. The Research Progress of Bufalin in the Treatment of Hepatocellular Carcinoma
   Han-yu Jiang et al, 2022, OncoTargets and Therapy CrossRef
9. Modulating pancreatic cancer microenvironment: The efficacy of Huachansu in mouse models via TGF-β/Smad pathway
   Yuehui Wang et al, 2024, Journal of Ethnopharmacology CrossRef
10. Flower-like Composite Material Delivery of Co-Packaged Lenvatinib and Bufalin Prevents the Migration and Invasion of Cholangiocarcinoma
    Zhouyu Ning et al, 2022, Nanomaterials CrossRef
11. Bufalin inhibits peritoneal dissemination of gastric cancer through endothelial nitric oxide synthase‐mitogen‐activated protein kinases signaling pathway
    Dan Zou et al, 2021, The FASEB Journal CrossRef
12. Metabolites from Bufo gargarizans (Cantor, 1842): A review of traditional uses, pharmacological activity, toxicity and quality control
    Xiang Zhan et al, 2020, Journal of Ethnopharmacology CrossRef
13. miR-219 regulates liver cancer stem cell expansion via E-cadherin pathway
    Anfeng Si et al, 2019, Cell Cycle CrossRef
14. Bufalin induces apoptosis via mitochondrial ROS-mediated caspase-3 activation in HCT-116 and SW620 human colon cancer cells
    Di Wu et al, 2019, Drug and Chemical Toxicology CrossRef
15. Reappraisal of the Roles of the Sonic Hedgehog Signaling Pathway in Hepatocellular Carcinoma
    Kuo-Shyang Jeng et al, 2024, Cancers CrossRef
16. Underlying mechanisms and drug intervention strategies for the tumour microenvironment
    Haoze Li et al, 2021, Journal of Experimental & Clinical Cancer Research CrossRef
17. Toad venom: A comprehensive review of chemical constituents, anticancer activities, and mechanisms
    Fang‐Jie Li et al, 2021, Archiv der Pharmazie CrossRef
18. Bufalin for an innovative therapeutic approach against cancer
    Laura Soumoy et al, 2022, Pharmacological Research CrossRef
19. Determination of Endogenous Bufalin in Serum of Patients With Hepatocellular Carcinoma Based on HPLC-MS/MS
    Mengfei Han et al, 2020, Frontiers in Oncology CrossRef
20. Smad4 regulates TGF-β1-mediated hedgehog activation to promote epithelial-to-mesenchymal transition in pancreatic cancer cells by suppressing Gli1 activity
    Hangcheng Guo et al, 2024, Computational and Structural Biotechnology Journal CrossRef
21. Targeting molecular signal transduction pathways in hepatocellular carcinoma and its implications for cancer therapy
    Ishfaq Hassan Mir et al, 2021, Cell Biology International CrossRef
22. Effect of PI3K/AKT/mTOR Signaling Pathway on Regulating and Controlling the Anti-Invasion and Metastasis of Hepatoma Cells by Bufalin
    Xia Sheng et al, 2021, Recent Patents on Anti-Cancer Drug Discovery CrossRef
23. Bufalin-Mediated Regulation of Cell Signaling Pathways in Different Cancers: Spotlight on JAK/STAT, Wnt/β-Catenin, mTOR, TRAIL/TRAIL-R, and Non-Coding RNAs
    Ammad Ahmad Farooqi et al, 2023, Molecules CrossRef
24. Traditional Chinese medicine for prevention and treatment of hepatocellular carcinoma: A focus on epithelial-mesenchymal transition
    Jia-jia Li et al, 2021, Journal of Integrative Medicine CrossRef
25. Therapeutic potential of targeting membrane-spanning proteoglycan SDC4 in hepatocellular carcinoma
    Heng Yang et al, 2021, Cell Death & Disease CrossRef
26. Molecular mechanisms underlying the�antimetastatic activity of bufalin (Review)
    Jie Wang et al, 2018, Molecular and Clinical Oncology CrossRef
27. Prognostic Analysis of Hepatocellular Carcinoma With Hepatitis C Virus Infection Using Epithelial-Mesenchymal Transition Gene Profiles
    Masaki Ueno et al, 2020, Journal of Surgical Research CrossRef